Compare Piramal Healthcare with Biocon Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs BIOCON - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

BIOCON  
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES BIOCON PIRAMAL ENTERPRISES/
BIOCON
 
P/E (TTM) x 17.6 31.1 56.7% View Chart
P/BV x 1.2 4.0 30.2% View Chart
Dividend Yield % 1.9 0.2 779.6%  

Financials

 PIRAMAL ENTERPRISES   BIOCON
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
BIOCON
Mar-19
PIRAMAL ENTERPRISES/
BIOCON
5-Yr Chart
Click to enlarge
High Rs3,303707 466.9%   
Low Rs1,797554 324.4%   
Sales per share (Unadj.) Rs716.591.9 779.6%  
Earnings per share (Unadj.) Rs79.716.7 477.0%  
Cash flow per share (Unadj.) Rs107.924.2 446.4%  
Dividends per share (Unadj.) Rs28.001.00 2,800.0%  
Dividend yield (eoy) %1.10.2 692.5%  
Book value per share (Unadj.) Rs1,477.5101.6 1,453.8%  
Shares outstanding (eoy) m184.45600.00 30.7%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x3.66.9 51.9%   
Avg P/E ratio x32.037.7 84.8%  
P/CF ratio (eoy) x23.626.1 90.6%  
Price / Book Value ratio x1.76.2 27.8%  
Dividend payout %35.16.0 587.0%   
Avg Mkt Cap Rs m470,292378,330 124.3%   
No. of employees `0007.86.1 127.5%   
Total wages/salary Rs m22,50411,653 193.1%   
Avg. sales/employee Rs Th16,899.48,994.3 187.9%   
Avg. wages/employee Rs Th2,877.71,900.7 151.4%   
Avg. net profit/employee Rs Th1,879.91,635.3 115.0%   
INCOME DATA
Net Sales Rs m132,15355,144 239.7%  
Other income Rs m3,1281,444 216.6%   
Total revenues Rs m135,28156,588 239.1%   
Gross profit Rs m66,29015,883 417.4%  
Depreciation Rs m5,2024,478 116.2%   
Interest Rs m44,097709 6,219.7%   
Profit before tax Rs m20,11912,140 165.7%   
Minority Interest Rs m3,1949 35,486.7%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,6112,123 405.6%   
Profit after tax Rs m14,70110,026 146.6%  
Gross profit margin %50.228.8 174.2%  
Effective tax rate %42.817.5 244.8%   
Net profit margin %11.118.2 61.2%  
BALANCE SHEET DATA
Current assets Rs m122,74248,228 254.5%   
Current liabilities Rs m310,81030,376 1,023.2%   
Net working cap to sales %-142.332.4 -439.6%  
Current ratio x0.41.6 24.9%  
Inventory Days Days2368 33.8%  
Debtors Days Days3986 45.4%  
Net fixed assets Rs m116,90464,130 182.3%   
Share capital Rs m3693,000 12.3%   
"Free" reserves Rs m272,16157,980 469.4%   
Net worth Rs m272,53060,980 446.9%   
Long term debt Rs m270,19615,766 1,713.8%   
Total assets Rs m856,261121,924 702.3%  
Interest coverage x1.518.1 8.0%   
Debt to equity ratio x1.00.3 383.5%  
Sales to assets ratio x0.20.5 34.1%   
Return on assets %6.98.8 78.0%  
Return on equity %5.416.4 32.8%  
Return on capital %12.416.8 74.1%  
Exports to sales %028.1 0.0%   
Imports to sales %018.9 0.0%   
Exports (fob) Rs mNA15,506 0.0%   
Imports (cif) Rs mNA10,399 0.0%   
Fx inflow Rs m15,20015,506 98.0%   
Fx outflow Rs m4,88910,399 47.0%   
Net fx Rs m10,3125,107 201.9%   
CASH FLOW
From Operations Rs m-115,97511,546 -1,004.5%  
From Investments Rs m-8,265-7,138 115.8%  
From Financial Activity Rs m107,525-2,417 -4,448.7%  
Net Cashflow Rs m-16,6502,103 -791.7%  

Share Holding

Indian Promoters % 52.9 40.4 130.9%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 4.0 8.4 47.6%  
FIIs % 26.6 10.7 248.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 19.9 82.9%  
Shareholders   93,274 109,995 84.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   CIPLA  SANOFI INDIA  ALKEM LABORATORIES  ORCHID PHARMA LTD  NOVARTIS  

Compare PIRAMAL ENTERPRISES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

RBI Monetary Policy Takeaways, Gold Hits Record High, and Top Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a positive note yesterday after the RBI kept the repo rate unchanged at 4%.

Related Views on News

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY20); Net Profit Up 11.7% (Quarterly Result Update)

Feb 5, 2020 | Updated on Feb 5, 2020

For the quarter ended December 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 11.7% YoY). Sales on the other hand came in at Rs 38 bn (up 9.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, BIOCON has posted a net profit of Rs 3 bn (down 30.5% YoY). Sales on the other hand came in at Rs 16 bn (up 19.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY20); Net Profit Up 16.5% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 16.5% YoY). Sales on the other hand came in at Rs 36 bn (up 14.6% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

More Views on News

Most Popular

These 5 Smallcaps Deserve a Place in Your Coffee Can Portfolio(Profit Hunter)

Jul 28, 2020

When it comes to quality stocks, doing less is more.

Before You Buy Your First Electric Vehicle Consider Buying this Stock(Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

How to Buy Gold and Silver(Fast Profits Daily)

Jul 27, 2020

In this video I'll show you how to buy bullion the right way.

Elon Musk Gives Us a Trading Opportunity(Fast Profits Daily)

Jul 28, 2020

Elon Musk made a statement recently which I believe, gives us a fast profit trading opportunity.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Aug 6, 2020 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES - AUROBINDO PHARMA COMPARISON

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS